The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Solovey N.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Shcherba V.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Sadovskaya I.K.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Atrashkevich O.M.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Worse than an aspid

Authors:

Solovey N.V., Shcherba V.V., Sadovskaya I.K., Atrashkevich O.M.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2023;(3): 64‑70

Read: 654 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Solovey NV, Shcherba VV, Sadovskaya IK, Atrashkevich OM. Worse than an aspid. Non Nocere. New Therapeutic Journal. 2023;(3):64‑70. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Nervous system lesions associated with varicella-zoster virus.

Authors:

Solovey N.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Shcherba V.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Sadovskaya I.K.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Atrashkevich O.M.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Close metadata

References:

  1. Nagel MA, Gilden D. Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol. 2014 Jun;27(3):356-360.  https://doi.org/10.1097/WCO.0000000000000092
  2. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP; steering committee and investigators group. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect. 2012 Aug;18(8):808-819.  https://doi.org/10.1111/j.1469-0691.2011.03705.x
  3. Persson A, Bergström T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease – viral load, clinical manifestations and sequels. J Clin Virol. 2009 Nov;46(3):249-253. https://doi.org/10.1016/j.jcv.2009.07.014. 
  4. Grahn A, Nilsson S, Nordlund A, Lindén T, Studahl M. Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study. J Neurol. 2013 Nov;260(11):2761-2769. https://doi.org/10.1007/s00415-013-7057-1
  5. de Ory F, Avellón A, Echevarría JE, Sánchez-Seco MP, Trallero G, Cabrerizo M, Casas I, Pozo F, Fedele G, Vicente D, Pena MJ, Moreno A, Niubo J, Rabella N, Rubio G, Pérez-Ruiz M, Rodríguez-Iglesias M, Gimeno C, Eiros JM, Melón S, Blasco M, López-Miragaya I, Varela E, Martinez-Sapiña A, Rodríguez G, Marcos MÁ, Gegúndez MI, Cilla G, Gabilondo I, Navarro JM, Torres J, Aznar C, Castellanos A, Guisasola ME, Negredo AI, Tenorio A, Vázquez-Morón S. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol. 2013 Mar;85(3):554-562.  https://doi.org/10.1002/jmv.23470
  6. Hausfater P, Fillet AM, Rozenberg F, Arthaud M, Trystram D, Huraux JM, Lebon P, Riou B. Prevalence of viral infection markers by polymerase chain reaction amplification and interferon-alpha measurements among patients undergoing lumbar puncture in an emergency department. J Med Virol. 2004 May;73(1):137-146.  https://doi.org/10.1002/jmv.20068
  7. Koskiniemi M, Rantalaiho T, Piiparinen H, von Bonsdorff CH, Färkkilä M, Järvinen A, Kinnunen E, Koskiniemi S, Mannonen L, Muttilainen M, Linnavuori K, Porras J, Puolakkainen M, Räihä K, Salonen EM, Ukkonen P, Vaheri A, Valtonen V; Study Group. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol. 2001 Oct;7(5):400-408.  https://doi.org/10.1080/135502801753170255
  8. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis. 2011 Feb 1;203(3):316-323.  https://doi.org/10.1093/infdis/jiq066
  9. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010 Dec;10(12):835-844.  https://doi.org/10.1016/S1473-3099(10)70222-X
  10. Mailles A, Stahl JP; Steering Committee and Investigators Group. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis. 2009 Dec 15;49(12):1838-1847. https://doi.org/10.1086/648419
  11. Rack AL, Grote V, Streng A, Belohradsky BH, Heinen F, von Kries R, Liese JG. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010 Jan;42(1):40-48.  https://doi.org/10.1016/j.pediatrneurol.2009.07.012
  12. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007 Dec;92(12):1062-106.  https://doi.org/10.1136/adc.2007.123232
  13. Bozzola E, Bozzola M, Tozzi AE, Calcaterra V, Longo D, Krzystofiak A, Villani A. Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr. 2014 Jun 19;40:57.  https://doi.org/10.1186/1824-7288-40-57
  14. Orme HT, Smith AG, Nagel MA, Bert RJ, Mickelson TS, Gilden DH. VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology. 2007 Jul 24;69(4):398-400.  https://doi.org/10.1212/01.wnl.0000266390.27177.7b
  15. Nagel MA, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, VanEgmond EM, Stenmark K, Frid M, Mahalingam R, Wellish M, Choe A, Cordery-Cotter R, Cohrs RJ, Gilden D. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology. 2011 Jul 26;77(4):364-370.  https://doi.org/10.1212/WNL.0b013e3182267bfa
  16. Breuer J, Pacou M, Gautier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014 Jul 8;83(2):e27-33.  https://doi.org/10.1212/WNL.0000000000000584
  17. Lewis GW. Zoster sine herpete. Br Med J. 1958 Aug 16;2(5093):418-421.  https://doi.org/10.1136/bmj.2.5093.418
  18. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol. 1994 May;35(5):530-533.  https://doi.org/10.1002/ana.410350505
  19. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013 Sep 3;81(10):928-930.  https://doi.org/10.1212/WNL.0b013e3182a3516e
  20. Boogaard S, Heymans MW, de Vet HC, Peters ML, Loer SA, Zuurmond WW, Perez RS. Predictors of Persistent Neuropathic Pain – A Systematic Review. Pain Physician. 2015 Sep-Oct;18(5):433-457. 
  21. Murakami S, Nakashiro Y, Mizobuchi M, Hato N, Honda N, Gyo K. Varicella-zoster virus distribution in Ramsay Hunt syndrome revealed by polymerase chain reaction. Acta Otolaryngol. 1998 Mar;118(2):145-149.  https://doi.org/10.1080/00016489850154829
  22. Kinishi M, Amatsu M, Mohri M, Saito M, Hasegawa T, Hasegawa S. Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx. 2001 Aug;28(3):223-226.  https://doi.org/10.1016/s0385-8146(01)00055-4
  23. Uri N, Greenberg E, Kitzes-Cohen R, Doweck I. Acyclovir in the treatment of Ramsay Hunt syndrome. Otolaryngol Head Neck Surg. 2003 Oct;129(4):379-381.  https://doi.org/10.1016/s0194-5998(03)01305-6
  24. Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol. 1997 Mar;41(3):353-357.  https://doi.org/10.1002/ana.410410310
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.